Brokerages Set HealthEquity, Inc. (NASDAQ:HQY) Price Target at $107.23

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been given an average rating of “Moderate Buy” by the thirteen brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $107.23.

A number of brokerages have issued reports on HQY. BTIG Research lifted their price objective on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. The Goldman Sachs Group began coverage on HealthEquity in a research report on Friday. They issued a “neutral” rating and a $108.00 price target for the company. Barrington Research reissued an “outperform” rating and set a $105.00 price objective on shares of HealthEquity in a research report on Friday, September 20th. Bank of America lifted their target price on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, September 4th.

HealthEquity Stock Up 3.5 %

Shares of HealthEquity stock opened at $102.40 on Friday. The company’s fifty day simple moving average is $85.54 and its two-hundred day simple moving average is $81.25. HealthEquity has a 12-month low of $62.10 and a 12-month high of $103.12. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The company has a market cap of $8.94 billion, a P/E ratio of 85.33, a PEG ratio of 1.55 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The firm had revenue of $299.93 million for the quarter, compared to the consensus estimate of $284.48 million. Research analysts anticipate that HealthEquity will post 2.27 EPS for the current year.

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now owns 54,719 shares in the company, valued at $4,540,582.62. The trade was a 13.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Frank Corvino sold 1,247 shares of the stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the transaction, the director now directly owns 4,823 shares of the company’s stock, valued at $387,093.98. This trade represents a 20.54 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 10,536 shares of company stock valued at $884,517. Company insiders own 2.20% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of HQY. International Assets Investment Management LLC purchased a new stake in shares of HealthEquity in the second quarter worth approximately $35,000. Paladin Wealth LLC purchased a new stake in HealthEquity in the third quarter worth $39,000. GAMMA Investing LLC lifted its position in shares of HealthEquity by 114.8% during the second quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock worth $51,000 after purchasing an additional 318 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of HealthEquity during the second quarter valued at $73,000. Finally, Quarry LP grew its holdings in shares of HealthEquity by 418.8% in the third quarter. Quarry LP now owns 1,349 shares of the company’s stock worth $110,000 after purchasing an additional 1,089 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.